| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: ready for prime time?
|
Delgado, Julio
|
|
|
114 |
13 |
p. 2581-2588
|
article
|
| 2 |
Ambrogio et al. p130Cas mediates the transforming properties of the anaplastic lymphoma kinase. Blood. 2005;106(12):3907–3916.
|
|
|
|
114 |
13 |
p. 2851
|
article
|
| 3 |
A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF
|
Zanardelli, Sara
|
|
|
114 |
13 |
p. 2819-2828
|
article
|
| 4 |
A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma
|
Purdue, Mark P.
|
|
|
114 |
13 |
p. 2730-2732
|
article
|
| 5 |
Aurora kinase A is a target of Wnt/β-catenin involved in multiple myeloma disease progression
|
Dutta-Simmons, Jui
|
|
|
114 |
13 |
p. 2699-2708
|
article
|
| 6 |
Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells
|
Fiskus, Warren
|
|
|
114 |
13 |
p. 2733-2743
|
article
|
| 7 |
Defining prior therapy in myelodysplastic syndromes and criteria for relapsed and refractory disease: implications for clinical trial design and enrollment
|
Sekeres, Mikkael A.
|
|
|
114 |
13 |
p. 2575-2580
|
article
|
| 8 |
Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia
|
Russell, Lisa J.
|
|
|
114 |
13 |
p. 2688-2698
|
article
|
| 9 |
Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial
|
Zenz, Thorsten
|
|
|
114 |
13 |
p. 2589-2597
|
article
|
| 10 |
Determining the rise in BCR-ABL RNA that optimally predicts a kinase domain mutation in patients with chronic myeloid leukemia on imatinib
|
Press, Richard D.
|
|
|
114 |
13 |
p. 2598-2605
|
article
|
| 11 |
Distinct spatio-temporal Ca2+ signaling elicited by integrin α2β1 and glycoprotein VI under flow
|
Mazzucato, Mario
|
|
|
114 |
13 |
p. 2793-2801
|
article
|
| 12 |
Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose
|
Pulsipher, Michael A.
|
|
|
114 |
13 |
p. 2606-2616
|
article
|
| 13 |
Dynamic accumulation of plasmacytoid dendritic cells in lymph nodes is regulated by interferon-β
|
Gao, Yunfei
|
|
|
114 |
13 |
p. 2623-2631
|
article
|
| 14 |
Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies
|
Fandy, Tamer E.
|
|
|
114 |
13 |
p. 2764-2773
|
article
|
| 15 |
Editorial Board
|
|
|
|
114 |
13 |
p. i
|
article
|
| 16 |
Enhanced efficacy of recombinant FVIII in noncovalent complex with PEGylated liposome in hemophilia A mice
|
Pan, Junliang
|
|
|
114 |
13 |
p. 2802-2811
|
article
|
| 17 |
Eosinophil viability is increased by acidic pH in a cAMP- and GPR65-dependent manner
|
Kottyan, Leah C.
|
|
|
114 |
13 |
p. 2774-2782
|
article
|
| 18 |
HIV: getting to the heart of DARCness
|
Nibbs, Robert J.B.
|
|
|
114 |
13 |
p. 2570-2571
|
article
|
| 19 |
Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome
|
Roumenina, Lubka T.
|
|
|
114 |
13 |
p. 2837-2845
|
article
|
| 20 |
Identification of cancer stem cells in a Tax-transgenic (Tax-Tg) mouse model of adult T-cell leukemia/lymphoma
|
Yamazaki, Jumpei
|
|
|
114 |
13 |
p. 2709-2720
|
article
|
| 21 |
Identification of monoclonal B-cell lymphocytosis among sibling transplant donors for chronic lymphocytic leukemia patients
|
Giudice, Ilaria Del
|
|
|
114 |
13 |
p. 2848-2849
|
article
|
| 22 |
Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation
|
Piconese, Silvia
|
|
|
114 |
13 |
p. 2639-2648
|
article
|
| 23 |
Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia
|
Linger, Rachel M.A.
|
|
|
114 |
13 |
p. 2678-2687
|
article
|
| 24 |
Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties
|
François, Moïra
|
|
|
114 |
13 |
p. 2632-2638
|
article
|
| 25 |
Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors
|
Bryceson, Yenan T.
|
|
|
114 |
13 |
p. 2657-2666
|
article
|
| 26 |
Missteps in “tango” for epigenome targeting
|
Robertson, Keith D.
|
|
|
114 |
13 |
p. 2569-2570
|
article
|
| 27 |
Mutational spectrum at GATA1 provides insights into mutagenesis and leukemogenesis in Down syndrome
|
Cabelof, Diane C.
|
|
|
114 |
13 |
p. 2753-2763
|
article
|
| 28 |
NK antibody therapy: KIR-ative intent
|
Shah, Nina
|
|
|
114 |
13 |
p. 2567-2568
|
article
|
| 29 |
Nolte-'t Hoen et al. Activated T cells recruit exosomes secreted by dendritic cells via LFA-1. Blood. 2009;113(9):1977–1981.
|
|
|
|
114 |
13 |
p. 2851
|
article
|
| 30 |
Platelet integrin signaling: wherefore art thou?
|
Schmaier, Alec A.
|
|
|
114 |
13 |
p. 2571-2572
|
article
|
| 31 |
Pneumoviruses infect eosinophils and elicit MyD88-dependent release of chemoattractant cytokines and interleukin-6
|
Dyer, Kimberly D.
|
|
|
114 |
13 |
p. 2649-2656
|
article
|
| 32 |
Preclinical characterization of 1-7F9, a novel human anti–KIR receptor therapeutic antibody that augments natural killer–mediated killing of tumor cells
|
Romagné, Francois
|
|
|
114 |
13 |
p. 2667-2677
|
article
|
| 33 |
Restoration of NET formation by gene therapy in CGD controls aspergillosis
|
Bianchi, Matteo
|
|
|
114 |
13 |
p. 2619-2622
|
article
|
| 34 |
Role of TNFRSF13B variants in patients with common variable immunodeficiency
|
Martínez-Pomar, Natalia
|
|
|
114 |
13 |
p. 2846-2848
|
article
|
| 35 |
RUNX1 regulates phosphoinositide 3-kinase/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemia
|
Edwards, Holly
|
|
|
114 |
13 |
p. 2744-2752
|
article
|
| 36 |
Selective depletion of alloreactive T cells by targeted therapy of heat shock protein 90: a novel strategy for control of graft-versus-host disease
|
Stuehler, Claudia
|
|
|
114 |
13 |
p. 2829-2836
|
article
|
| 37 |
Super factor B-gets atypical HUS
|
Conway, Edward M.
|
|
|
114 |
13 |
p. 2572-2574
|
article
|
| 38 |
Tai et al. CS1 promotes multiple myeloma cell adhesion, clonogenic growth, and tumorigenicity via c-maf–mediated interactions with bone marrow stromal cells. Blood. 2009;113(18):4309–4318.
|
|
|
|
114 |
13 |
p. 2852
|
article
|
| 39 |
“Tax-ing” the cancer stem cell
|
Feuer, Gerold
|
|
|
114 |
13 |
p. 2568-2569
|
article
|
| 40 |
The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry
|
Kulkarni, Hemant
|
|
|
114 |
13 |
p. 2783-2792
|
article
|
| 41 |
The importance of bone marrow examination in determining complete response to therapy in patients with multiple myeloma
|
Chee, Cheng E.
|
|
|
114 |
13 |
p. 2617-2618
|
article
|
| 42 |
Therapeutic potential of an anti-CD79b antibody–drug conjugate, anti–CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma
|
Dornan, David
|
|
|
114 |
13 |
p. 2721-2729
|
article
|
| 43 |
The role of CBFβ in AML1-ETO's activity
|
Park, Sangho
|
|
|
114 |
13 |
p. 2849-2850
|
article
|
| 44 |
Thrombin induces the expression of oncostatin M via AP-1 activation in human macrophages: a link between coagulation and inflammation
|
Kastl, Stefan P.
|
|
|
114 |
13 |
p. 2812-2818
|
article
|
Journal description